Sign In

Login

Password

Forgot Password ? Sign Up

Ospemifen (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ospemifen" in Serbian language version.

refsWebsite
Global rank Serbian rank
11doi.org
2nd place
4th place
10nih.gov
4th place
8th place
1harvard.edu
18th place
28th place

doi.org (Global: 2nd place; Serbian: 4th place)

  • Taras TL, Wurz GT, DeGregorio MW: In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer. J Steroid Biochem Mol Biol. ;77(4-5):271-9. Taras, T. L.; Wurz, G. T.; Degregorio, M. W. (2001 Jun). „In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer”. The Journal of Steroid Biochemistry and Molecular Biology. 77 (4–5): 271—279. PMID 11457665. doi:10.1016/s0960-0760(01)00066-8.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Voipio SK, Komi J, Kangas L, Halonen K, DeGregorio MW, Erkkola RU: Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women. Maturitas. Voipio, S. K.; Komi, J.; Kangas, L.; Halonen, K.; Degregorio, M. W.; Erkkola, R. U. (новембар 2002). „Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women”. Maturitas. 43 (3): 207—14. PMID 12443837. doi:10.1016/s0378-5122(02)00206-2. 
  • Rutanen EM, Heikkinen J, Halonen K, Komi J, Lammintausta R, Ylikorkala O: Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial. Menopause. ;Rutanen, E. M.; Heikkinen, J.; Halonen, K.; Komi, J.; Lammintausta, R.; Ylikorkala, O. (2003 Sep-Oct). „Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: A double-blind, randomized trial”. Menopause (New York, N.Y.). 10 (5): 433—9. PMID 14501605. doi:10.1097/01.GME.0000063609.62485.27.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Ylikorkala O, Cacciatore B, Halonen K, Lassila R, Lammintausta R, Rutanen EM, Heikkinen J, Komi J: Effects of ospemifene, a novel SERM, on vascular markers and function in healthy, postmenopausal wo men. Menopause. ;Ylikorkala, O.; Cacciatore, B.; Halonen, K.; Lassila, R.; Lammintausta, R.; Rutanen, E. M.; Heikkinen, J.; Komi, J. (2003 Sep-Oct). „Effects of ospemifene, a novel SERM, on vascular markers and function in healthy, postmenopausal women”. Menopause (New York, N.Y.). 10 (5): 440—7. PMID 14501606. doi:10.1097/01.GME.0000063566.84134.98.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Tolonen A, Koskimies P, Turpeinen M, Uusitalo J, Lammintausta R, Pelkonen O: Ospemifene metabolism in humans in vitro and in vivo: metabolite identification, quantitation, and CYP assignment of major hydroxylations. Drug Metabol Drug Interact. 14:1-9.Tolonen, A.; Koskimies, P.; Turpeinen, M.; Uusitalo, J.; Lammintausta, R.; Pelkonen, O. (2013 May). „Ospemifene metabolism in humans in vitro and in vivo: Metabolite identification, quantitation, and CYP assignment of major hydroxylations”. Drug Metabolism and Drug Interactions. 28 (3): 153—161. PMID 23729558. doi:10.1515/dmdi-2013-0016.  Проверите вредност парамет(а)ра за датум: |date= (помоћ).
  • McCall JL, DeGregorio MW: Pharmacologic evaluation of ospemifene. Expert Opin Drug Metab Toxicol. McCall, Jamie L.; Degregorio, Michael W. (јун 2010). „Pharmacologic evaluation of ospemifene”. Expert Opinion on Drug Metabolism & Toxicology. 6 (6): 773—9. PMID 20429673. doi:10.1517/17425255.2010.487483. ..
  • Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709 Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126. 
  • Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889 Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958. 
  • Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o. 
  • Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t. 
  • Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e. 

harvard.edu (Global: 18th place; Serbian: 28th place)

adsabs.harvard.edu

  • Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o. 

nih.gov (Global: 4th place; Serbian: 8th place)

ncbi.nlm.nih.gov

  • Taras TL, Wurz GT, DeGregorio MW: In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer. J Steroid Biochem Mol Biol. ;77(4-5):271-9. Taras, T. L.; Wurz, G. T.; Degregorio, M. W. (2001 Jun). „In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer”. The Journal of Steroid Biochemistry and Molecular Biology. 77 (4–5): 271—279. PMID 11457665. doi:10.1016/s0960-0760(01)00066-8.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Voipio SK, Komi J, Kangas L, Halonen K, DeGregorio MW, Erkkola RU: Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women. Maturitas. Voipio, S. K.; Komi, J.; Kangas, L.; Halonen, K.; Degregorio, M. W.; Erkkola, R. U. (новембар 2002). „Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women”. Maturitas. 43 (3): 207—14. PMID 12443837. doi:10.1016/s0378-5122(02)00206-2. 
  • Rutanen EM, Heikkinen J, Halonen K, Komi J, Lammintausta R, Ylikorkala O: Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial. Menopause. ;Rutanen, E. M.; Heikkinen, J.; Halonen, K.; Komi, J.; Lammintausta, R.; Ylikorkala, O. (2003 Sep-Oct). „Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: A double-blind, randomized trial”. Menopause (New York, N.Y.). 10 (5): 433—9. PMID 14501605. doi:10.1097/01.GME.0000063609.62485.27.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Ylikorkala O, Cacciatore B, Halonen K, Lassila R, Lammintausta R, Rutanen EM, Heikkinen J, Komi J: Effects of ospemifene, a novel SERM, on vascular markers and function in healthy, postmenopausal wo men. Menopause. ;Ylikorkala, O.; Cacciatore, B.; Halonen, K.; Lassila, R.; Lammintausta, R.; Rutanen, E. M.; Heikkinen, J.; Komi, J. (2003 Sep-Oct). „Effects of ospemifene, a novel SERM, on vascular markers and function in healthy, postmenopausal women”. Menopause (New York, N.Y.). 10 (5): 440—7. PMID 14501606. doi:10.1097/01.GME.0000063566.84134.98.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Tolonen A, Koskimies P, Turpeinen M, Uusitalo J, Lammintausta R, Pelkonen O: Ospemifene metabolism in humans in vitro and in vivo: metabolite identification, quantitation, and CYP assignment of major hydroxylations. Drug Metabol Drug Interact. 14:1-9.Tolonen, A.; Koskimies, P.; Turpeinen, M.; Uusitalo, J.; Lammintausta, R.; Pelkonen, O. (2013 May). „Ospemifene metabolism in humans in vitro and in vivo: Metabolite identification, quantitation, and CYP assignment of major hydroxylations”. Drug Metabolism and Drug Interactions. 28 (3): 153—161. PMID 23729558. doi:10.1515/dmdi-2013-0016.  Проверите вредност парамет(а)ра за датум: |date= (помоћ).
  • McCall JL, DeGregorio MW: Pharmacologic evaluation of ospemifene. Expert Opin Drug Metab Toxicol. McCall, Jamie L.; Degregorio, Michael W. (јун 2010). „Pharmacologic evaluation of ospemifene”. Expert Opinion on Drug Metabolism & Toxicology. 6 (6): 773—9. PMID 20429673. doi:10.1517/17425255.2010.487483. ..
  • Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709 Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126. 
  • Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889 Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958. 
  • Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t. 
  • Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.